A Practical Method for Synthesizing Iptacopan
Sign Up to like & getrecommendations! Published in 2024 at "Molecules"
DOI: 10.3390/molecules29102289
Abstract: Iptacopan, the first orally available small-molecule complement factor B inhibitor, was developed by Novartis AG of Switzerland. Iptacopan for the treatment of PNH was just approved by the FDA in December 2023. Other indications for… read more here.
Keywords: method synthesizing; practical method; iptacopan; synthesizing iptacopan ... See more keywords